Journal of Cataract & Refractive Surgery
Volume 38, Issue 4 , Pages 677-682 , April 2012

Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy

Presented as a poster at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, USA, May 2011.

Received 8 July 2011 ,Revised 18 October 2011 ,Accepted 20 October 2011.

References 

  1. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566–583
  2. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–1444Available at: http://www.nejm.org/doi/pdf/10.1056/NEJMoa062655Accessed November 10, 2011
  3. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144:850–857
  4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431Available at: http://www.nejm.org/doi/pdf/10.1056/NEJMoa054481Accessed November 10, 2011
  5. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008;145:239–248
  6. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg Visual acuity test. Invest Ophthalmol Vis Sci. 2006;47:1236–1240Available at: http://www.iovs.org/content/47/3/1236.full.pdfAccessed November 10, 2011
  7. Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M. The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers. 1998;29:286–294
  8. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology. 1996;103:1546–1554
  9. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology. 2007;114:278–282
  10. Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol. 2003;135:849–856
  11. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy; pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology. 2003;110:1960–1967
  12. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration; one-year outcomes. J Cataract Refract Surg. 2003;29:686–693
  13. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol. 2000;84:1343–1348Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1723362&blobtype=pdfAccessed November 20, 2011
  14. Sutter FKP, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Invest Ophthalmol Vis Sci. 2007;48:1472–1475Available at: http://www.iovs.org/cgi/reprint/48/4/1472Accessed November 10, 2011
  15. Baatz H, Darawsha R, Ackermann H, Scharioth GB, de Ortueta D, Pavlidis M, et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:1079–1083Available at: http://www.iovs.org/cgi/reprint/49/3/1079Accessed November 10, 2011
  16. Dong LM, Stark WJ, Jefferys JL, Al-Hazzaa S, Bressler SB, Solomon SD, et al. Progression of age-related macular degeneration after cataract surgery. Arch Ophthalmol. 2009;127:1412–1419Available at: http://archopht.ama-assn.org/cgi/reprint/127/11/1412.pdfAccessed November 10, 2011
  17. Hooper CY, Lamoureux EL, Lim L, Fraser-Bell S, Yeoh J, Harper CA, et al. Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial. Clin Exp Ophthalmol. 2009;37:570–576Available at: http://onlinelibrary.wiley.com/doi/10.1111/j.1442-9071.2009.02095.x/pdfAccessed November 10, 2011
  18. Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR, Bressler SB, et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study; AREDS report 25. Ophthalmology. 2009;116:297–303
  19. Klein BEK. Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery?. [editorial] Arch Ophthalmol. 2009;127:1528–1529
  20. Furino C, Ferrara A, Cardascia N, Besozzi G, Alessio G, Sborgia L, et al. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration. J Cataract Refract Surg. 2009;35:1518–1522
  21. Jonas JB, Spandau UHM, Schlichtenbrede F, Libondi T, Vossmerbaeumer U, von Baltz S. Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration. J Ocul Pharmacol Ther. 2007;23:599–600

PII: S0886-3350(12)00013-2

doi: 10.1016/j.jcrs.2011.10.036

Journal of Cataract & Refractive Surgery
Volume 38, Issue 4 , Pages 677-682 , April 2012

Article Tools